Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 15, 2023

BUY
$5.04 - $8.6 $31,111 - $53,087
6,173 New
6,173 $31,000
Q2 2019

Aug 14, 2019

SELL
$17.38 - $26.88 $1.22 Million - $1.88 Million
-70,000 Closed
0 $0
Q1 2019

May 15, 2019

BUY
$9.2 - $21.21 $644,000 - $1.48 Million
70,000 New
70,000 $1.21 Million
Q4 2018

Feb 14, 2019

SELL
$9.61 - $14.02 $168,126 - $245,279
-17,495 Closed
0 $0
Q3 2018

Nov 14, 2018

SELL
$8.1 - $13.6 $20,290 - $34,068
-2,505 Reduced 12.53%
17,495 $238,000
Q2 2018

Aug 14, 2018

BUY
$11.2 - $15.0 $224,000 - $300,000
20,000 New
20,000 $229,000

Others Institutions Holding MGTX

About MeiraGTx Holdings plc


  • Ticker MGTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,010,700
  • Market Cap $288M
  • Description
  • MeiraGTx Holdings plc, a clinical stage gene therapy company, focusing on developing treatments for patients with serious diseases. The company develops various therapies for ocular diseases, including inherited blindness, as well as Xerostomia following radiation treatment for head and neck cancers; degenerative diseases; neurodegenerative dise...
More about MGTX
Track Steven Cohen's Portfolio

Track Steven Cohen Portfolio

Follow Steven Cohen (Point72 Asset Management, L.P.) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Point72 Asset Management, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Point72 Asset Management, L.P. and Steven Cohen with notifications on news.